Proto Labs (PRLB) Liabilities and Shareholders Equity (2011 - 2026)

Proto Labs has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $791.3 million in Q2 2026.

• Liabilities and Shareholders Equity for Q2 2026 came in at $791.3 million, up 6.46% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.1 billion (up 3.77% YoY), and the FY2025 annual result was $763.4 million, up 2.68% from the prior year.
• Liabilities and Shareholders Equity improved to $791.3 million in Q2 2026, from $778.6 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $934.8 million in Q1 2022 and troughed at $737.4 million in Q1 2025.
• A 5-year average of $793.5 million and a median of $774.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity slipped 15.4%; it then climbed 6.46% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $802.2 million in 2022, then slipped by 3.72% to $772.4 million in 2023, then dropped by 3.73% to $743.5 million in 2024, then increased by 2.68% to $763.4 million in 2025, then grew by 3.65% to $791.3 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $791.3 million in Q2 2026, $778.6 million in Q1 2026, and $763.4 million in Q4 2025.